This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
D13 | Ann: Shareholder Update | 26/03/19 | 18 | 9.0K | |||
|
|||||||
D13 | Ann: Initial Director's Interest Notice | 19/03/19 | 2 | 4.6K | |||
|
|||||||
D13 | Ann: Initial Director's Interest Notice | 11:41 | 0 | 184 | |||
|
|||||||
D13 | Ann: Final Director's Interest Notice x2 | 11:41 | 0 | 217 | |||
|
|||||||
D13 | Ann: Half Yearly Report and Accounts | 01/03/19 | 5 | 1.1K | |||
|
|||||||
D13 | Ann: Reconstitution of Board of Directors | 27/02/19 | 4 | 998 | |||
|
|||||||
D13 | Ann: $10m Line of Credit & Update | 26/02/19 | 18 | 5.9K | |||
|
|||||||
D13 | Ann: Request for Extension to Voluntary Suspension | 18/02/19 | 25 | 9.5K | |||
|
See All Discussions